Secretory phospholipase A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavage

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Intensive Care Medicine

• Publication date

  2008-07-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00134-008-1224-3PMID 18648767
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bile Acid-Induced Lung Injury in Newborn Infants: A Bronchoalveolar Lavage Fluid Study

  2008cited by this paper
• Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.

  2007cited by this paper
• Epithelial lining fluid free IGF-I-to-PAPP-A ratio is associated with bronchopulmonary dysplasia in preterm infants.

  2007cited by this paper
• European consensus guidelines on the management of neonatal respiratory distress syndrome

  2007cited by this paper
• 2005 American Heart Association (AHA) Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC) of Pediatric and Neonatal Patients: Neonatal Resuscitation Guidelines

  2006cited by this paper
• Experimental evaluation of errors in the measurement of respiratory parameters of the newborn performed by a continuous flow neonatal ventilator

  2006influential reference
• Phospholipases A2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome*

  2005cited by this paper
• Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase A(2)-mediated surfactant dysfunction.

  2005cited by this paper
• Clara cell secretory protein and phospholipase A2 activity modulate acute ventilator-induced lung injury in mice.

  2005cited by this paper
• Phospholipase A2 and acute lung injury: it's just not that simple.

  2005cited by this paper
• SPSS 14.0 Advanced Statistical Procedures Companion

  2005cited by this paper
• A program based on a 'selective' least-squares method for respiratory mechanics monitoring in ventilated patients

  2003cited by this paper
• Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure

  2003cited by this paper
• Induction of type-IIA secretory phospholipase A2 in animal models of acute lung injury

  2003influential reference
• Interaction of secreted phospholipase A2 and pulmonary surfactant and its pathophysiological relevance in acute respiratory distress syndrome.

  2003influential reference
• Biochemistry of Lipids, Lipoproteins and Membranes

  2002cited by this paper
• Transcriptional regulation of inflammatory secreted phospholipases A(2).

  2000cited by this paper
• Surfactant Treatment of Neonates With Respiratory Failure and Group B Streptococcal Infection

  2000cited by this paper
• A role for phospholipase A2 in ARDS pathogenesis.

  1999influential reference
• Avery's Diseases of the Newborn

  1998cited by this paper
• Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.

  1998cited by this paper
• Regulatory functions of phospholipase A2.

  1997cited by this paper
• The growing phospholipase A2 superfamily of signal transduction enzymes.

  1997cited by this paper
• Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A.

  1997cited by this paper
• Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group.

  1996cited by this paper
• Aerosolized Surfactant in Adults with Sepsis-Induced Acute Respiratory Distress Syndrome

  1996cited by this paper
• Modulation by dexamethasone of phospholipase A2 activities in endotoxemic guinea pigs.

  1995cited by this paper
• Bronchoalveolar lavage fluid phospholipase A2 activities are increased in human adult respiratory distress syndrome.

  1995cited by this paper
• 1-Hexadecyl-2-arachidonoylthio-2-deoxy-sn-glycero-3-phosphorylcholine as a substrate for the microtiterplate assay of human cytosolic phospholipase A2.

  1994cited by this paper
• Surfactant therapy in full-term neonates with severe respiratory failure.

  1993cited by this paper
• Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.

  1991cited by this paper
• Neonatal diagnosis of respiratory distress syndrome.

  1989cited by this paper
• Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.

  1986cited by this paper

• Biochemical Features and Clinical Factors Influencing Response to Surfactant Treatment among Infants Born Late Preterm with Respiratory Distress Syndrome.

  2025cites this paper
• Curosurf Versus BLES in the Treatment of Preterm Neonates with Respiratory Distress Syndrome: A Randomized Clinical Trial

  2025cites this paper
• Effect of different CPAP levels on ultrasound-assessed lung aeration and gas exchange in neonates

  2024cites this paper
• Neonatal ARDS Treated With Electrical Impedance Tomography-Guided Recruitment Maneuvers and Surfactant-Vehicled Budesonide

  2024cites this paper
• Assessment of myocardial function in late preterm and term infants with transient tachypnea of the newborn using tissue Doppler imaging - a pilot observational study

  2023cites this paper
• Ultrasound‐assessed lung aeration, oxygenation and respiratory care in neonatal bile acid pneumonia: A nested case–control study

  2023cites this paper
• Surfactant status assessment and personalized therapy for surfactant deficiency or dysfunction.

  2023cites this paper
• Early life surfactant protein-D levels in broncho-alveolar lavage fluids of extremely preterm neonates.

  2023cites this paper
• Effect of preterm chorioamnionitis on lung ultrasound score used to guide surfactant replacement

  2023cites this paper
• Evolution of ultrasound-assessed lung aeration and gas exchange in respiratory distress syndrome and transient tachypnea of the neonate.

  2022cites this paper
• Ultrasound-assessed lung aeration correlates with respiratory system compliance in adults and neonates with acute hypoxemic restrictive respiratory failure: an observational prospective study

  2022cites this paper
• Secretory phospholipase A2 expression and activity in preterm clinical chorioamnionitis with fetal involvement.

  2022cites this paper
• Strategies to protect surfactant and enhance its activity

  2021cites this paper
• Pulmonary surfactant: a unique biomaterial with life-saving therapeutic applications.

  2021cites this paper
• Effect of inspired gas temperature on lung mechanics and gas exchangein neonates in normothermia or therapeutic hypothermia.

  2021cites this paper
• Surfactant-secreted phospholipase A2 interaction and respiratory outcome in preterm neonates.

  2020cites this paper
• Surfactant Injury in the Early Phase of Severe Meconium Aspiration Syndrome.

  2020cites this paper
• A Multicenter Lung Ultrasound Study on Transient Tachypnea of the Neonate

  2019cites this paper
• Effect of cooling on lung secretory phospholipase A2 activity in vitro, ex vivo, and in vivo.

  2019cites this paper
• Porcine vs bovine surfactant therapy for preterm neonates with RDS: systematic review with biological plausibility and pragmatic meta-analysis of respiratory outcomes

  2019cites this paper
• Continuous positive airway pressure (CPAP) vs noninvasive positive pressure ventilation (NIPPV) vs noninvasive high frequency oscillation ventilation (NHFOV) as post-extubation support in preterm neonates: protocol for an assessor-blinded, multicenter, randomized controlled trial

  2019cites this paper
• Pediatric Pulmonology

  2019cites this paper
• An Unsettled Promise: The Newborn Piglet Model of Neonatal Acute Respiratory Distress Syndrome (NARDS). Physiologic Data and Systematic Review

  2019cites this paper
• Lung Ultrasound Score Predicts Surfactant Need in Extremely Preterm Neonates

  2018cites this paper
• The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity.

  2017cites this paper
• Nasal High Frequency Oscillation Ventilation(NHFOV) vs. Nasal Continuous Positive Airway Pressure(NCPAP) vs Nasal Intermittent Positive Pressure Ventilation(NIPPV) as Post-extubation Respiratory Support in Preterm Infants With Respiratory Distress Syndrome:a Multicenter Randomized Controlled Trial

  2017cites this paper
• A Noninvasive Surfactant Adsorption Test Predicting the Need for Surfactant Therapy in Preterm Infants Treated with Continuous Positive Airway Pressure

  2017cites this paper
• This item is the archived peer-reviewed author-version of: Bio-inspired materials in drug delivery: exploring the role of pulmonary surfactant in sIRNA inhalation therapy

  2016cites this paper
• Effect of prenatal steroidal inhibition of sPLA2 in a rat model of preterm lung.

  2016cites this paper
• Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy.

  2015cites this paper
• Surfactant from neonatal to pediatric ICU: bench and bedside evidence.

  2014cites this paper
• Structure-function relationships in pulmonary surfactant membranes: from biophysics to therapy.

  2014cites this paper
• Mechanical induction of group V phospholipase A(2) causes lung inflammation and acute lung injury.

  2013cites this paper
• Clara Cell Protein Expression in Human Neonates During Respiratory Distress Syndrome

  2012cites this paper
• Technical problems with dynamic compliance evaluation in neonates and infants

  2012cites this paper
• Varespladib Inhibits Secretory Phospholipase A2 in Bronchoalveolar Lavage of Different Types of Neonatal Lung Injury

  2012cites this paper
• Secretory phospholipase A2 pathway in various types of lung injury in neonates and infants: a multicentre translational study

  2011cites this paper
• STABLE ISOTOPE TRACERS TO ESTIMATE SURFACTANT METABOLISM IN NEWBORNS WITH RESPIRATORY DISTRESS SYNDROME

  2011cites this paper
• Feasibility of extracellular competitive inhibition of phospholipase A2 in neonatal and pediatric lung injury

  2011cites this paper
• Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates

  2011cites this paper
• Secretory phospholipase A2 pathway during pediatric acute respiratory distress syndrome: A preliminary study

  2011cites this paper
• The pharmacological management of intrahepatic cholestasis of pregnancy.

  2011cites this paper
• Mitochondrial DNA damage analysis in bronchoalveolar lavage cells of preterm infants.

  2010cites this paper
• Low-concentration ozone reacts with plasmalogen glycerophosphoethanolamine lipids in lung surfactant.

  2010cites this paper
• Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice.

  2009cites this paper
• Year in review in Intensive Care Medicine, 2008: III. Paediatrics, Ethics, outcome research and critical care organization, sedation, pharmacology and miscellanea

  2009cites this paper
• Flow-cycled versus time-cycled sIPPV in preterm babies with RDS: a breath-to-breath randomised cross-over trial

  2009cites this paper